Published in Gynecol Oncol on June 01, 2003
Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems. J Clin Oncol (2009) 1.27
Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007. J Cancer Res Clin Oncol (2008) 1.05
Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience. Ann Surg Oncol (2013) 1.02
A mouse model of uterine leiomyosarcoma. Am J Pathol (2004) 0.99
A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma. Clin Cancer Res (2012) 0.99
Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma. Gynecol Oncol (2011) 0.97
Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer. Br J Cancer (2011) 0.97
Dual targeting of mTOR and aurora-A kinase for the treatment of uterine Leiomyosarcoma. Clin Cancer Res (2012) 0.95
Treatment of early uterine sarcomas: disentangling adjuvant modalities. World J Surg Oncol (2009) 0.95
Uterine leiomyosarcoma: 14-year two-center experience of 31 cases. Cancer Res Treat (2009) 0.95
Current and future options in the management and treatment of uterine sarcoma. Ther Adv Med Oncol (2014) 0.90
Novel uterine sarcoma preoperative diagnosis score predicts the need for surgery in patients presenting with a uterine mass. Springerplus (2014) 0.89
Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients. J Gynecol Oncol (2014) 0.85
Uterine sarcoma. Clinico-pathological characteristics and outcome. Saudi Med J (2014) 0.84
Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma. Am J Transl Res (2015) 0.82
Leiomyosarcoma: investigation of prognostic factors for risk-stratification model. Int J Clin Oncol (2015) 0.81
Effects of menopausal hormone therapy on uterine myoma in menopausal women. J Menopausal Med (2013) 0.80
Postoperative radiotherapy improves local control and survival in patients with uterine leiomyosarcoma. Radiat Oncol (2013) 0.80
Tamoxifen in breast cancer ipse dixit in uterine malignant mixed Müllerian tumor and sarcoma-A report of 8 cases and review of the literature. Rep Pract Oncol Radiother (2013) 0.80
Let-7 repression leads to HMGA2 overexpression in uterine leiomyosarcoma. J Cell Mol Med (2008) 0.79
Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia. Mod Pathol (2016) 0.79
Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin. Sarcoma (2015) 0.79
Preoperative diagnosis of usual leiomyoma, atypical leiomyoma, and leiomyosarcoma. Sarcoma (2014) 0.78
Prognostic factors and survival in patients treated surgically for recurrent metastatic uterine leiomyosarcoma. Int J Surg Oncol (2014) 0.77
Leiomyosarcoma of the uterine cervix associated with pregnancy: A case report and review of literature. Gynecol Oncol Rep (2016) 0.75
Molecular targeted therapy in gynaecologic malignancies: primer for radiologists. Br J Radiol (2016) 0.75
FIGO staging for uterine sarcomas: can the revised 2008 staging system predict survival outcome better? Yonsei Med J (2014) 0.75
Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma. J Gynecol Oncol (2017) 0.75
The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma. PLoS One (2015) 0.75
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment. Oncologist (2017) 0.75
Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report. J Med Case Rep (2017) 0.75
Primary uterine osteosarcoma presenting synchronously with bilateral breast carcinomas. BMJ Case Rep (2014) 0.75
Clinical Characteristics, Surgical Management and Adjuvant Therapy of Patients with Uterine Leiomyosarcoma: 27 Years of Experience. Geburtshilfe Frauenheilkd (2011) 0.75
Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol (2015) 0.75
Laparoscopic surgery on broken points for uterine sarcoma in the early stage decrease prognosis. Sci Rep (2016) 0.75
The uncovered story of leiomyosarcoma of the cervix: a rare case report and review of literature. BMJ Case Rep (2013) 0.75
Uterine sarcoma with ambiguous histomorphology: A case report. Gynecol Oncol Rep (2017) 0.75
Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma. J Gynecol Oncol (2017) 0.75
The value of perioperative imaging in patients with uterine sarcomas. Gynecol Oncol (2009) 0.75
Uterine leiomyosarcoma in asian patients: validation of the revised Federation of gynecology and obstetrics staging system and identification of prognostic classifiers. Oncologist (2012) 0.75
Uterine leiomyosarcoma with central nervous system metastases. Ecancermedicalscience (2015) 0.75
Treatment of recurrent metastatic uterine leiomyosarcoma of the spine: a multimodality approach using resection, radiosurgery, and chemotherapy. J Neurosurg Spine (2015) 0.75
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report. J Med Case Rep (2016) 0.75
Improved clinical trial enrollments for uterine leiomyosarcoma patients after gynecologic oncology partnership with a sarcoma center. Gynecol Oncol (2015) 0.75
Uterine leiomyosarcoma manifesting as a tricuspid valve mass. Case Rep Oncol (2013) 0.75
Vaginal metastasis as the initial presentation of leiomyosarcoma: a case report. BMC Cancer (2017) 0.75
[Uterine sarcoma treatment]. Pathologe (2009) 0.75
Current Status of Uterine Leiomyosarcoma in the Tohoku Region: Results of the Tohoku Translational Center Development Network Survey. Int J Clin Oncol (2017) 0.75
Primary leiomyosarcoma of the fallopian tube. Int J Clin Oncol (2010) 0.75
Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care (2003) 19.69
Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation (2006) 11.78
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol (2004) 7.36
Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med (2002) 5.10
Association of perceived medical errors with resident distress and empathy: a prospective longitudinal study. JAMA (2006) 5.06
Lung cancer screening with CT: Mayo Clinic experience. Radiology (2003) 4.72
Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J Clin Oncol (2010) 4.30
Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital. Mayo Clin Proc (2008) 4.19
Burnout and suicidal ideation among U.S. medical students. Ann Intern Med (2008) 3.96
Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol (2008) 3.94
Association of resident fatigue and distress with perceived medical errors. JAMA (2009) 3.70
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health (2008) 3.68
Medication-assisted therapies--tackling the opioid-overdose epidemic. N Engl J Med (2014) 3.35
The well-being of physicians. Am J Med (2003) 3.29
The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients. Cancer (2007) 3.28
Career fit and burnout among academic faculty. Arch Intern Med (2009) 3.15
Personal life events and medical student burnout: a multicenter study. Acad Med (2006) 2.98
Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol (2005) 2.98
Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study. Am J Hematol (2009) 2.84
Agreement between patient reports of cardiovascular disease and patient medical records. Mayo Clin Proc (2005) 2.71
Risk factors for developing endometrial cancer after benign endometrial sampling. Obstet Gynecol (2012) 2.70
Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9. J Clin Oncol (2010) 2.57
Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol (2006) 2.55
Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes (2006) 2.48
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol (2013) 2.48
The learning curve of robotic hysterectomy. Obstet Gynecol (2013) 2.47
An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol (2004) 2.45
The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest (2004) 2.44
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial. Support Care Cancer (2010) 2.43
Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc (2008) 2.42
Premature menopause or early menopause: long-term health consequences. Maturitas (2009) 2.33
Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol (2007) 2.32
Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst (2007) 2.31
Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol (2010) 2.28
Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer. Obstet Gynecol (2009) 2.27
Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration. Menopause (2009) 2.27
Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int (2008) 2.26
Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. J Clin Oncol (2006) 2.22
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. Cancer Res (2010) 2.19
Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol (2006) 2.18
A multicenter study of burnout, depression, and quality of life in minority and nonminority US medical students. Mayo Clin Proc (2006) 2.14
How do distress and well-being relate to medical student empathy? A multicenter study. J Gen Intern Med (2007) 2.10
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol (2002) 2.09
Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol (2005) 2.09
The Impact of Stigma and Personal Experiences on the Help-Seeking Behaviors of Medical Students With Burnout. Acad Med (2015) 2.06
Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecol Oncol (2008) 2.01
Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene (2003) 2.00
Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol (2002) 1.97
Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades. Eur Heart J (2006) 1.97
Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy. Ophthalmology (2006) 1.96
Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer (2007) 1.94
Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause (2008) 1.92
Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol (2004) 1.90
Patterns of distress in US medical students. Med Teach (2011) 1.87
Avoiding burnout: the personal health habits and wellness practices of US surgeons. Ann Surg (2012) 1.85
Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. J Vasc Interv Radiol (2011) 1.85
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage (2007) 1.83
Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology (2002) 1.79
The association between impact factors and language of general internal medicine journals. Swiss Med Wkly (2006) 1.79
The learning environment and medical student burnout: a multicentre study. Med Educ (2009) 1.79
Acupuncture for hot flashes: a randomized, sham-controlled clinical study. Menopause (2007) 1.78
Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. J Clin Oncol (2008) 1.77
Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol (2006) 1.77
Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer. J Clin Oncol (2006) 1.76
Physician satisfaction and burnout at different career stages. Mayo Clin Proc (2013) 1.75
Quality of life and symptom burden among long-term lung cancer survivors. J Thorac Oncol (2012) 1.74
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic. Clin J Am Soc Nephrol (2007) 1.68
The medical marriage: a national survey of the spouses/partners of US physicians. Mayo Clin Proc (2013) 1.67
Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol (2004) 1.66
Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma. J Clin Oncol (2002) 1.65
Folate receptor overexpression is associated with poor outcome in breast cancer. Int J Cancer (2007) 1.65
Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol (2011) 1.65
Personal consequences of malpractice lawsuits on American surgeons. J Am Coll Surg (2011) 1.64
Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions. J Am Acad Orthop Surg (2010) 1.63
Burnout and serious thoughts of dropping out of medical school: a multi-institutional study. Acad Med (2010) 1.63
Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol (2008) 1.61
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Qual Life Res (2010) 1.61
Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia. J Clin Oncol (2010) 1.61
Endometrial stromal sarcoma: treatment and patterns of recurrence. Int J Gynecol Cancer (2009) 1.61
The prevalence of weight concerns in a smoking abstinence clinical trial. Addict Behav (2005) 1.60
Quality of life after breast cancer surgery: What have we learned and where should we go next? J Surg Oncol (2009) 1.60
Physicians' attitudes toward complementary and alternative medicine and their knowledge of specific therapies: a survey at an academic medical center. Evid Based Complement Alternat Med (2006) 1.60
Single item measures of emotional exhaustion and depersonalization are useful for assessing burnout in medical professionals. J Gen Intern Med (2009) 1.59
Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res (2002) 1.57
Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest (2004) 1.55
An interactive individualized intervention to promote behavioral change to increase personal well-being in US surgeons. Ann Surg (2014) 1.52
Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer. Mayo Clin Proc (2010) 1.51
Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol (2006) 1.50
A retrospective cohort study of factors that affect healing in long-term care residents with chronic wounds. Ostomy Wound Manage (2009) 1.48
Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc (2002) 1.48
Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst (2013) 1.47
Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysis. Radiology (2006) 1.46
Two-dimensional echocardiographic methods for assessment of left atrial volume. Am J Cardiol (2006) 1.46
Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards. J Pain Symptom Manage (2010) 1.46
Factors associated with resilience to and recovery from burnout: a prospective, multi-institutional study of US medical students. Med Educ (2010) 1.45
Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Support Care Cancer (2002) 1.44
Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria. AIDS Care (2009) 1.43